These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27322032)

  • 1. Positron emission tomography imaging of coronary atherosclerosis.
    Moss AJ; Adamson PD; Newby DE; Dweck MR
    Future Cardiol; 2016 Jul; 12(4):483-96. PubMed ID: 27322032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology.
    Evans NR; Tarkin JM; Chowdhury MM; Warburton EA; Rudd JH
    Curr Atheroscler Rep; 2016 Jun; 18(6):30. PubMed ID: 27108163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?
    Rudd JH; Narula J; Strauss HW; Virmani R; Machac J; Klimas M; Tahara N; Fuster V; Warburton EA; Fayad ZA; Tawakol AA
    J Am Coll Cardiol; 2010 Jun; 55(23):2527-35. PubMed ID: 20513592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiodiagnostic studies in atherosclerosis].
    Sergienko VB
    Vestn Rentgenol Radiol; 2007; (1):11-8. PubMed ID: 18274137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovation in medical imaging to improve disease staging, therapeutic intervention, and clinical outcomes.
    Daghem M; Newby DE
    Atherosclerosis; 2020 Aug; 306():75-84. PubMed ID: 32331772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging and Targeting Coronary Artery Inflammation.
    West HW; Antoniades C
    Antioxid Redox Signal; 2021 May; 34(15):1217-1243. PubMed ID: 32458744
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical utility of hybrid imaging for the identification of vulnerable plaque and vulnerable patients.
    Bing R; Driessen RS; Knaapen P; Dweck MR
    J Cardiovasc Comput Tomogr; 2019; 13(5):242-247. PubMed ID: 31345766
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kitagawa T; Yamamoto H; Toshimitsu S; Sasaki K; Senoo A; Kubo Y; Tatsugami F; Awai K; Hirokawa Y; Kihara Y
    Atherosclerosis; 2017 Aug; 263():385-392. PubMed ID: 28528743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.
    Kang WJ
    Korean J Radiol; 2015; 16(6):1257-61. PubMed ID: 26576114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis imaging to refine cardiovascular risk assessment in diabetic patients: Computed tomography and positron emission tomography applications.
    Raggi P
    Atherosclerosis; 2018 Apr; 271():77-83. PubMed ID: 29477560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction.
    Joshi NV; Toor I; Shah AS; Carruthers K; Vesey AT; Alam SR; Sills A; Hoo TY; Melville AJ; Langlands SP; Jenkins WS; Uren NG; Mills NL; Fletcher AM; van Beek EJ; Rudd JH; Fox KA; Dweck MR; Newby DE
    J Am Heart Assoc; 2015 Aug; 4(9):e001956. PubMed ID: 26316523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of atherosclerosis.
    Tarkin JM; Joshi FR; Rajani NK; Rudd JH
    Future Cardiol; 2015; 11(1):115-31. PubMed ID: 25606707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary Artery Microcalcification: Imaging and Clinical Implications.
    Vancheri F; Longo G; Vancheri S; Danial JSH; Henein MY
    Diagnostics (Basel); 2019 Sep; 9(4):. PubMed ID: 31547506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective.
    Krishnan S; Otaki Y; Doris M; Slipczuk L; Arnson Y; Rubeaux M; Dey D; Slomka P; Berman DS; Tamarappoo B
    J Nucl Med; 2017 Mar; 58(3):359-364. PubMed ID: 28183988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.
    Robson PM; Dweck MR; Trivieri MG; Abgral R; Karakatsanis NA; Contreras J; Gidwani U; Narula JP; Fuster V; Kovacic JC; Fayad ZA
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1103-1112. PubMed ID: 28109921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Role of PET in Detecting and Characterizing Atherosclerosis.
    Høilund-Carlsen PF; Moghbel MC; Gerke O; Alavi A
    PET Clin; 2019 Apr; 14(2):197-209. PubMed ID: 30826018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational Coronary Atherosclerosis Imaging with PET.
    Adamson PD; Newby DE; Dweck MR
    Cardiol Clin; 2016 Feb; 34(1):179-86. PubMed ID: 26590788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Body Atherosclerosis Imaging by Positron Emission Tomography/Magnetic Resonance Imaging: From Mice to Nonhuman Primates.
    Calcagno C; Pérez-Medina C; Mulder WJM; Fayad ZA
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1123-1134. PubMed ID: 32237905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive assessment of hypoxia in rabbit advanced atherosclerosis using ¹⁸F-fluoromisonidazole positron emission tomographic imaging.
    Mateo J; Izquierdo-Garcia D; Badimon JJ; Fayad ZA; Fuster V
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):312-20. PubMed ID: 24508668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.